Halozyme Therapeutics | Crediti Commerciali

Prezzo Delle Azioni
81.23
Cambio Giornaliero
2.81 3.58%
Mensile
8.15%
Annuale
42.26%
Q1 Previsione
78.74




Crediti Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 139.44M 19.75M 2025-09
Agios Pharmaceuticals USD 5.03M 43K 2025-09
Alnylam Pharmaceuticals USD 964.77M 397.66M 2025-09
Amarin USD 127.31M 8.18M 2025-09
Amgen USD 8.49B 211M 2025-09
Baxter International USD 1.77B 127M 2025-06
Cytokinetics USD 1.81M 6.6M 2025-09
DBV Technologies USD 15.97M 279K 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Halozyme Therapeutics USD 346.04M 29.7M 2025-09
Ionis Pharmaceuticals USD 24.61M 27.97M 2025-09
MannKind USD 17.38M 9.76M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
United Therapeutics USD 297.7M 81.6M 2025-09


Halozyme Therapeutics Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.